Answers are grounded in this paper and cite their sources.
Background: The adverse effects of corticosteroid therapy in the treatment of asthma have been extensively documented and explored over the past several decades. Prominent among these adverse effects are osteoporosis, cataracts and osteonecrosis. We assessed the prevalence of these three well known side effects of corticosteroid therapy for asthma in asthmatics versus non asthmatics from a general adult population of 3.5 million individuals. Methods: Using the Colorado all payers claims database with dates of service January 1, 2017 through June 30, 2020, we determined the prevalence of osteoporosis, cataracts and osteonecrosis by asthma severity, age and sex as compared with an age and sex matched non asthmatic comparator group. Results: Asthmatics generally showed an earlier onset and higher prevalence of these three side effects which correlated with asthma severity, often reaching statistically significant divergence from the non asthmatic comparator group. Patterns of prevalence with regard to both age and sex were distinctive for each side effect. Conclusion: Based on our findings, we suggest customized screening guidelines for osteoporosis, cataracts and osteonecrosis for specific sub-populations of asthmatics as defined by age, sex and asthma severity.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: